The human leucocyte antigen CD48 (MEM-102) is closely related to the activation marker Blast-1
Language English Country United States Media print
Document type Journal Article
PubMed
1999350
DOI
10.1007/bf00210823
Knihovny.cz E-resources
- MeSH
- CD48 Antigen MeSH
- Antigens, Surface chemistry MeSH
- Antigens, CD chemistry MeSH
- Antigens, Differentiation chemistry MeSH
- Cloning, Molecular MeSH
- Leukocytes, Mononuclear immunology MeSH
- Humans MeSH
- Membrane Glycoproteins chemistry MeSH
- Molecular Sequence Data MeSH
- Antibodies, Monoclonal MeSH
- Amino Acid Sequence MeSH
- Base Sequence MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- CD48 Antigen MeSH
- Antigens, Surface MeSH
- Antigens, CD MeSH
- CD48 protein, human MeSH Browser
- Antigens, Differentiation MeSH
- Membrane Glycoproteins MeSH
- Antibodies, Monoclonal MeSH
The glycosyl phosphatidylinositol (GPI)-linked antigen recognized by monoclonal antibody (mAb) MEM-102 is expressed on all peripheral blood lymphocytes, both resting and activated. Its properties are very similar to a previously described activation antigen, Blast-1. The amino acid sequence deduced from the structure of cloned cDNA is identical to that of the Blast-1 antigen except for a single amino acid residue. There are several other minor differences in the nucleotide sequence of the Blast-1 and MEM-102 cDNAs that do not affect the predicted structure of the polypeptide product. The amino acid sequence of the first 15 N-terminal residues of the antigen purified from Raji cells is found in the deduced sequence close to the presumed boundary between the leader peptide and mature polypeptide. Properties of the recombinant product expressed in COS cells are similar to the antigen isolated from peripheral blood mononuclear cells (PBMNCs) or B-and T-cells lines. The antigen purified on immobilized mAb MEM-102 is recognized by all six known CD48 mAbs under western blotting conditions. COS cells transfected with MEM-102 cDNA react with all the CD48 mAbs. It is concluded that mAb MEM-102 is directed against the as yet poorly characterized antigen CD48, which is therefore structurally closely related to Blast-1. Several possibilities are discussed that might account for the apparent discrepancy between the broad pan-leucocyte expression of the between the broad pan-leucocyte expression of the MEM-102/CD48 antigen and much more restricted expression of the epitope recognized by the previously described mAb defining the Blast-1 antigen.
See more in PubMed
Immunogenetics. 1990;31(3):188-90 PubMed
Nature. 1987 Oct 29-Nov 4;329(6142):840-2 PubMed
Mol Immunol. 1989 Feb;26(2):153-61 PubMed
Cell. 1984 Apr;36(4):897-906 PubMed
EMBO J. 1988 Oct;7(10 ):3087-91 PubMed
J Exp Med. 1989 Mar 1;169(3):1087-99 PubMed
J Biol Chem. 1987 Nov 25;262(33):16087-94 PubMed
Folia Biol (Praha). 1988;34(1):23-34 PubMed
Proc Natl Acad Sci U S A. 1987 May;84(10):3365-9 PubMed
Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7 PubMed
Folia Biol (Praha). 1989;35(5):289-97 PubMed
Cell. 1982 Sep;30(2):415-25 PubMed
J Exp Med. 1990 May 1;171(5):1431-42 PubMed
J Biol Chem. 1987 Jul 25;262(21):10035-8 PubMed
Proc Natl Acad Sci U S A. 1986 Nov;83(22):8718-22 PubMed
EMBO J. 1987 Dec 1;6(12):3695-701 PubMed
GENBANK
M37766, S80260, S80261, S80263, S80266, S80268, S81878, S81879, S81880, S81883